Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Expression and Transcriptome Sequencing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Gene Expression
1.2.3 Transcriptome Sequencing
1.3 Market by Application
1.3.1 Global Gene Expression and Transcriptome Sequencing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical and Biotechnology
1.3.3 Academic Research and Government Institutes
1.3.4 Hospitals and Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Expression and Transcriptome Sequencing Market Perspective (2018-2029)
2.2 Gene Expression and Transcriptome Sequencing Growth Trends by Region
2.2.1 Global Gene Expression and Transcriptome Sequencing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Expression and Transcriptome Sequencing Historic Market Size by Region (2018-2023)
2.2.3 Gene Expression and Transcriptome Sequencing Forecasted Market Size by Region (2024-2029)
2.3 Gene Expression and Transcriptome Sequencing Market Dynamics
2.3.1 Gene Expression and Transcriptome Sequencing Industry Trends
2.3.2 Gene Expression and Transcriptome Sequencing Market Drivers
2.3.3 Gene Expression and Transcriptome Sequencing Market Challenges
2.3.4 Gene Expression and Transcriptome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Expression and Transcriptome Sequencing Players by Revenue
3.1.1 Global Top Gene Expression and Transcriptome Sequencing Players by Revenue (2018-2023)
3.1.2 Global Gene Expression and Transcriptome Sequencing Revenue Market Share by Players (2018-2023)
3.2 Global Gene Expression and Transcriptome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Expression and Transcriptome Sequencing Revenue
3.4 Global Gene Expression and Transcriptome Sequencing Market Concentration Ratio
3.4.1 Global Gene Expression and Transcriptome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Expression and Transcriptome Sequencing Revenue in 2022
3.5 Gene Expression and Transcriptome Sequencing Key Players Head office and Area Served
3.6 Key Players Gene Expression and Transcriptome Sequencing Product Solution and Service
3.7 Date of Enter into Gene Expression and Transcriptome Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Expression and Transcriptome Sequencing Breakdown Data by Type
4.1 Global Gene Expression and Transcriptome Sequencing Historic Market Size by Type (2018-2023)
4.2 Global Gene Expression and Transcriptome Sequencing Forecasted Market Size by Type (2024-2029)
5 Gene Expression and Transcriptome Sequencing Breakdown Data by Application
5.1 Global Gene Expression and Transcriptome Sequencing Historic Market Size by Application (2018-2023)
5.2 Global Gene Expression and Transcriptome Sequencing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene Expression and Transcriptome Sequencing Market Size (2018-2029)
6.2 North America Gene Expression and Transcriptome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gene Expression and Transcriptome Sequencing Market Size by Country (2018-2023)
6.4 North America Gene Expression and Transcriptome Sequencing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Expression and Transcriptome Sequencing Market Size (2018-2029)
7.2 Europe Gene Expression and Transcriptome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gene Expression and Transcriptome Sequencing Market Size by Country (2018-2023)
7.4 Europe Gene Expression and Transcriptome Sequencing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Expression and Transcriptome Sequencing Market Size (2018-2029)
8.2 Asia-Pacific Gene Expression and Transcriptome Sequencing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gene Expression and Transcriptome Sequencing Market Size by Region (2018-2023)
8.4 Asia-Pacific Gene Expression and Transcriptome Sequencing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Expression and Transcriptome Sequencing Market Size (2018-2029)
9.2 Latin America Gene Expression and Transcriptome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gene Expression and Transcriptome Sequencing Market Size by Country (2018-2023)
9.4 Latin America Gene Expression and Transcriptome Sequencing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Expression and Transcriptome Sequencing Market Size (2018-2029)
10.2 Middle East & Africa Gene Expression and Transcriptome Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gene Expression and Transcriptome Sequencing Market Size by Country (2018-2023)
10.4 Middle East & Africa Gene Expression and Transcriptome Sequencing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Gene Expression and Transcriptome Sequencing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Gene Expression and Transcriptome Sequencing Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina Gene Expression and Transcriptome Sequencing Introduction
11.2.4 Illumina Revenue in Gene Expression and Transcriptome Sequencing Business (2018-2023)
11.2.5 Illumina Recent Development
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Detail
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) Gene Expression and Transcriptome Sequencing Introduction
11.3.4 QIAGEN (Exiqon) Revenue in Gene Expression and Transcriptome Sequencing Business (2018-2023)
11.3.5 QIAGEN (Exiqon) Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Gene Expression and Transcriptome Sequencing Introduction
11.4.4 Agilent Technologies Revenue in Gene Expression and Transcriptome Sequencing Business (2018-2023)
11.4.5 Agilent Technologies Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Gene Expression and Transcriptome Sequencing Introduction
11.5.4 Roche Revenue in Gene Expression and Transcriptome Sequencing Business (2018-2023)
11.5.5 Roche Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Detail
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Gene Expression and Transcriptome Sequencing Introduction
11.6.4 GE Healthcare Revenue in Gene Expression and Transcriptome Sequencing Business (2018-2023)
11.6.5 GE Healthcare Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Gene Expression and Transcriptome Sequencing Introduction
11.7.4 Bio-Rad Laboratories Revenue in Gene Expression and Transcriptome Sequencing Business (2018-2023)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Fluidigm
11.8.1 Fluidigm Company Detail
11.8.2 Fluidigm Business Overview
11.8.3 Fluidigm Gene Expression and Transcriptome Sequencing Introduction
11.8.4 Fluidigm Revenue in Gene Expression and Transcriptome Sequencing Business (2018-2023)
11.8.5 Fluidigm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details